SUBSCRIBE
SUBSCRIBE

Pharm Country

Connecticut, New York, New Jersey, Pennsylvania and Rhode Island

The northeast region of Pharm Country typically attracts a good deal of venture capital dollars, particularly as onlookers seek direction from Wall Street.

Major research universities, including University of Pennsylvania, Penn State University, Carnegie Mellon, Rutgers and Ivy Leagues Princeton, Yale, Cornell and Columbia contribute to this concentration of biopharma excellence.

Pharm Country is home to several state life sciences associations including BioCT, NewYorkBIO, BioNJ, Life Sciences PA and RI Bio.

NEWS FROM PHARM COUNTRY
Merck Research Laboratories headquarters in Silicon Valley
Mergers & acquisitions
Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy
August 9, 2024
 · 
2 min read
 · 
Tristan Manalac
FDA sign in front of its building in Maryland
Approvals
Citius Scores FDA Approval in Cutaneous T Cell Lymphoma
August 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Merck Research Laboratories in South San Francisco, California
Lung Cancer
Merck Halts Phase III Trial of Keytruda, Anti-TIGIT Combo in Small Cell Lung Cancer
August 8, 2024
 · 
2 min read
 · 
Tyler Patchen
MRI scans of the brain
Parkinson’s disease
Amneal Wins FDA Approval for Extended-Release Oral Parkinson’s Drug
August 8, 2024
 · 
2 min read
 · 
Tristan Manalac
FEATURED COMPANIES
See the latest job opportunities in Pharm Country
SEARCH JOBS
Illustration of employee being let go, falling out of chair
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
 · 
1 min read
 · 
Angela Gabriel
Pictured: J&J's office in Madrid, Spain
Regulatory
J&J Poised to Challenge Argenx With Myasthenia Gravis Filing for Nipocalimab
August 30, 2024
 · 
2 min read
 · 
Tristan Manalac
Merck Research Laboratories in South San Francisco, California
Cancer
Merck Axes Two Keytruda Phase III Cancer Trials Due to Disappointing Data
August 29, 2024
 · 
2 min read
 · 
Tristan Manalac
MORE COMPANIES IN PHARM COUNTRY
Arvinas Inc.
CSL
Daiichi Sankyo
Drexel University
Exelixis, Inc.
GenScript
Novo Nordisk
Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto
Deals
BMS Backs Out of $1.5B Deal, Returns Rights to Agenus for Bispecific Antibody
August 5, 2024
 · 
2 min read
 · 
Tyler Patchen
Illustration of a brain with DNA strands in the background
Opinion
Cell and Gene Therapy Shows Early Promise Against Alzheimer’s—But Challenges Remain
August 5, 2024
 · 
4 min read
 · 
Jia Jie Chen
3D rendering of a T-cell
Approvals
Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors
August 2, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk's corporate headquarters in Denmark
IRA
Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary
August 1, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
MORE COMPANIES IN PHARM COUNTRY
Azitra, Inc.
Bolden Therapeutics
Cybrexa Therapeutics
Focus Laboratories
Formation Bio
Idorsia Pharmaceuticals
Insmed Incorporated
Intra-Cellular Therapies, Inc
Johnson & Johnson Family of Companies
Ocugen, Inc.
OrphAI Therapeutics
Protara Therapeutics
Resilience
Sapience Therapeutics, Inc.
SELLAS Life Sciences Group
(PRNewsfoto/Soligenix, Inc.)
Soligenix
Syngene International Ltd
Tris Pharma
Volastra Therapeutics
Interested in appearing on the Hotbed Maps?
Find out how your organization can be featured!
LEARN MORE